Newer mechanism (centanafadine)

1 PRODUCT · CLASS OVERVIEW

Reviewed by Tariq Halim, MD · Last medical review: November 4, 2026 · Editorial policy

This page lists the 1 newer-mechanism product on this site, with the facts each product page cites from its FDA label. Open a product for full details, both patient and clinician views, and sources.

Overview

How it works

Schematic of centanafadine mechanism: norepinephrine, dopamine and serotonin reuptake inhibition (NET and DAT shown)
Centanafadine inhibits reuptake at the norepinephrine (NET), dopamine (DAT) and serotonin (SERT) transporters; the diagram shows NET and DAT. Labeling classifies it as a CNS stimulant.

Centanafadine blocks the reuptake of three brain messengers — norepinephrine, dopamine and serotonin — so more of each stays available between nerve cells.

Mechanism summary reused from the Simtriyo page (mechanism per its Prescribing Information, revised 10/2026).

Products

Formulation, duration and approved ages as stated on each product page (from its label). Generic: “Yes” means an FDA-approved generic or authorized generic is available.

ProductFormulationDurationApproved agesGeneric
Simtriyo
now marketable · check pharmacy availability
Extended-release capsuleTaken once each morning; the label does not describe when effects start or stop (peak about 5 hours).Adults, and children 6 years and older weighing at least 20 kgNo

Comparisons and guides

Sources

Each product’s current prescribing information, as cited on its page (other sources are listed on each product page):

EDUCATIONAL INFORMATION ONLY. Not medical advice. Medication decisions require individualized assessment by a qualified clinician. See the medical disclaimer.